William Russell
-
New tool in fight against pediatric diabetic retinopathy
The Children’s Diabetes Program at Monroe Carell Jr. Children’s Hospital at Vanderbilt recently unveiled its latest tool in helping to prevent diabetic retinopathy, the leading cause of acquired blindness in the United States. Read MoreJan 14, 2016
-
Diabetes trial targets body’s ability to produce insulin
Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment. Read MoreSep 10, 2015
-
Steeplechase again set to saddle up for Children’s Hospital
Nashville and Monroe Carell Jr. Children’s Hospital at Vanderbilt are gearing up for another year of one of America’s premier horse racing events, the Iroquois Steeplechase, now in its 74th year. Read MoreApr 9, 2015
-
VU tracking drug’s ability to prevent type 1 diabetes
Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D. Read MoreSep 12, 2013
-
Russell’s diabetes treatment efforts honored
The Middle Tennessee Chapter of the Juvenile Diabetes Research Foundation (JDRF) has awarded Vanderbilt’s William Russell, M.D., professor of Pediatrics and director of the division of Pediatric Endocrinology and Diabetes, its highest honor — the Living and Giving Award for support of people diagnosed with type 1 diabetes (T1D). Read MoreMay 9, 2013
-
National type I diabetes prevention trial now an option for younger children
A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old. Read MoreJul 31, 2012